Clinitech Laboratory

Clinitech Laboratory

46.04
-2.42
(-4.99%)
Market Cap
10.55 Cr
EPS
1.90
PE Ratio
31.88
Dividend Yield
0.00 %
52 Week High
98.99
52 Week Low
29.15
PB Ratio
1.25
Debt to Equity
0.07
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%

Company News

View All News
Caret
positive
Clinitech Laboratory Limited has introduced an in-house molecular department for all tests to enhance its medical services for patients. The company announced this development as a general update to improve its ability to cater to the medical needs of patients.
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
3,343.90
#1 28,013.69
53.58
#1 2,554.80
11.28
#1 492
24.30
53.84
1,041.70
10,696.92
71.71
699.70
20.11
144
22.54
49.96
2,063.00
10,686.73
72.31
1,346.30
10.64
146
18.90
50.67
1,223.70
6,484.93
62.47
702.20
20.80
91
60.25
43.41
826.60
2,669.07
34.01
742.70
25.65
78
14.53
59.14
310.30
1,616.07
48.88
255.90
15.11
31
19.48
58.14
1,425.85
1,223.72
24.91
96.47
25.47
49
11.50
43.06
304.55
968.79
#1 10.45
0.00
35.04
0
-35.12
65.36
260.00
508.13
19.33
147.04
#1 248.07
18
#1 444.44
49.91
199.50
138.92
98.11
41.80
6.34
2
0.00
50.73
Forecast
Actual
Growth Rate
Revenue Growth
-
Net Income Growth
-33.33 %
Cash Flow Change
31.25 %
ROE
-59.38 %
ROCE
-32.54 %
EBITDA Margin (Avg.)
-26.49 %

Yearly Financial Results

Annual Financials
2021
2022
2023
2024
2025
TTM
Revenue
5
7
6
6
9
0
Expenses
4
5
5
5
7
0
EBITDA
1
1
1
1
1
0
Operating Profit %
18 %
17 %
21 %
16 %
10 %
0 %
Depreciation
0
0
0
0
0
0
Interest
0
0
0
0
0
0
Profit Before Tax
1
1
1
1
1
0
Tax
0
0
0
0
0
0
Net Profit
0
1
1
0
0
0
EPS in ₹
6.04
3.42
4.09
2.37
1.90
0.00

Balance Sheet

Balance Sheet
2021
2022
2023
2024
2025
Total Assets
3
4
6
6
11
Fixed Assets
1
2
1
2
2
Current Assets
2
1
2
3
7
Capital Work in Progress
0
0
1
1
1
Investments
0
0
0
0
0
Other Assets
2
2
4
3
8
Total Liabilities
3
4
6
6
11
Current Liabilities
1
1
2
2
2
Non Current Liabilities
1
1
2
0
0
Total Equity
1
2
2
4
9
Reserve & Surplus
1
0
1
2
7
Share Capital
1
2
2
2
2

Cash Flow

Cash Flow
2021
2022
2023
2024
2025
Net Cash Flow
0
-0
1
-0
2
Investing Activities
1
-2
-1
1
-1
Operating Activities
0
1
1
-1
-1
Financing Activities
-1
0
0
0
4

Share Holding

% Holding
Jan 2024
Jul 2024
Sept 2024
Mar 2025
Promoter
83.63 %
61.58 %
61.58 %
61.58 %
FIIs
0.00 %
0.32 %
0.32 %
0.32 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
33.81 %
35.91 %
36.28 %
Others
16.37 %
4.30 %
2.20 %
1.83 %
No of Share Holders
24
450
346
303

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
23 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
23 Sept 2025 52.40 48.46
13 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Nov 2024 80.99 80.00
23 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
23 May 2025 42.71 42.71

Announcements

Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements2 days ago
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 28, 2025
Fixes Book Closure Date For 15Th AGMAug 26, 2025
Reg. 34 (1) Annual Report.Aug 26, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Aug 21, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Aug 21, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held Today Tuesday August 19 2025 At 12.00 NoonAug 19, 2025
Board Meeting Intimation for Board Meeting To Be Held On Tuesday August 19 2025 Through Video Conferencing At 12.00 NoonAug 13, 2025
Introduction Of In-House Molecular Department For All TestsAug 05, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 14, 2025
Appointment of Company Secretary and Compliance OfficerJun 06, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E June 06 2025 At 11.30 AM At Its Registered OfficeJun 06, 2025
Board Meeting Intimation for 02Nd Board Meeting Of The Company For FY 2025-26 At Its Registered OfficeJun 03, 2025
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerJun 02, 2025
Financial Results For 31.03.2025May 23, 2025
Undertaking For Non-Applicability Of Disclosure For RPTMay 23, 2025
Statement Of Deviation Or Variation As On March 31 2025 From Utilization Of Funds Raised Through IPOMay 23, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On Friday May 23 2025 At 11.30 AM For Approval Of Financial Results As On March 31 2025.May 23, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On Friday May 23 2025 At 11.30 AM For Approval Of Financial Results As On March 31 2025.May 23, 2025
Board Meeting Intimation for We Wish To Inform You That The Meeting Of The Board Of Directors Of The Company Will Be Held On Friday May 23 2025 Through Video Conferencing At 11.30 AM (IST)May 19, 2025
Non Applicability Disclosure W.R.T Large CorporateApr 16, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On March 25 2025 At The Registered Office Of The Company At 03.00 PM (IST).Mar 25, 2025
Closure of Trading WindowMar 24, 2025
Board Meeting Intimation for The Meeting Of The Board Of Directors Of The Company To Be Held On Tuesday March 25 2025 At 03.00 PM (IST) At The Registered Office Of The Company.Mar 19, 2025
Disclosure Under Regulation 30 Of SEBI (LODR) 2015.Feb 25, 2025
Reply Sought By The Exchange Under Regulation 30 Of SEBI (LODR) Regulations 2015.Feb 06, 2025
Clarification sought from Clinitech Laboratory LtdFeb 05, 2025
Integrated Filing (Governance)Jan 10, 2025
Statement Of Investor Complaints Under Regulation 13(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Jan 10, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 10, 2025
General Announcement Under Reg 30 Of SEBI (LODR)Jan 07, 2025
Submission Of Statement Of Deviation(S) Or Variation(S) Pursuant To Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Nov 13, 2024
Non Applicability Of Related Party TransactionsNov 13, 2024
Outcome Of The Board Meeting Held On Wednesday, November 13, 2024.Nov 13, 2024
Board Meeting Outcome for Outcome Of Meeting Of The Board Of Directors Of The Company Held Today, I.E., On November 13, 2024.Nov 13, 2024
Board Meeting Intimation for Financial Results For The Period Ended September 30, 2024Nov 06, 2024
Disclosure Of Statement Of Investor Complaints Under Regulation 13(3) Of SEBI (Listing Obligations And Disclosure Requirements), Regulations, 2015.Oct 16, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 14, 2024
Closure of Trading WindowSep 26, 2024
Opening Of New Collection Centre At New Panvel.Sep 14, 2024
Opening Of A New Branch Of The Company At Ulhasnagar.Aug 09, 2024
Listing of Equity Shares of Clinitech Laboratory LtdAug 01, 2024

Technical Indicators

RSI(14)
Neutral
48.61
ATR(14)
Less Volatile
2.64
STOCH(9,6)
Neutral
42.99
STOCH RSI(14)
Oversold
0.30
MACD(12,26)
Bearish
-0.64
ADX(14)
Strong Trend
32.05
UO(9)
Bearish
40.50
ROC(12)
Downtrend And Accelerating
-8.36
WillR(14)
Oversold
-94.97